Phase 4 Pancreatitis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with acute pancreatitis, based on at least two of the following: sudden, lasting pain in the upper abdomen; blood enzyme levels (amylase and/or lipase) at least three times higher than normal; or abnormal findings on a CT scan, MRI, or ultrasound.
- People whose pancreatitis is specifically linked to very high triglyceride (fat) levels in the blood, where other common causes such as gallstones or heavy alcohol use have been ruled out.
- People who were admitted to hospital within 72 hours of their symptoms starting.
- People whose pancreatitis has been assessed as mild within the first 48 hours of admission, meaning no organ failure and no complications have been detected.
- People aged between 18 and 65 years.
- People with no known allergy to microbiological agents (such as probiotics or similar products).
- People who have given written consent to take part in the trial.
Who may not be able to join:
- People whose pancreatitis is caused by gallstones, alcohol use, or another identified cause.
- People experiencing a flare-up of chronic pancreatitis, or who have a pancreatic tumour.
- People whose condition has been assessed as moderately severe or severe acute pancreatitis, or who score above certain thresholds on standard medical severity scoring tools within the first 48 hours (confirm with trial site for specific scoring details).
- People with seriously reduced kidney or liver function, based on specific blood test results.
- People who have an active infection, a current cancer diagnosis, a weakened immune system, or who need long-term immune-suppressing medication.
- People who have been diagnosed with diabetes.
- People who are pregnant or breastfeeding.
- People with a history of lactose intolerance.
- People who have used antibiotics, probiotics, prebiotics, or similar microbiological agents, or certain gut-motility medications, in the four weeks before enrolling in the trial.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 86-0592-2292232
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Mean Concentration of Serum Triglycerides (TG) in mmol/L at 5 ± 2 days.; Serum Concentration of C-Reactive Protein (CRP) at Day 5 (±2 days); Serum Concentration of Interleukin-6 (IL-6) at Day 5 (±2 days)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.